Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17618
Country/Region: Rwanda
Year: 2018
Main Partner: Society for Family Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $496,362 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $215,328
Sexual Prevention: Other Sexual Prevention (HVOP) $206,034
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $75,000
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 2019 3,492
HTS_SELF 15-19, Female, Directly-Assisted 2019 175
HTS_SELF 15-19, Female, Unassisted 2019 175
HTS_SELF 15-19, Male, Directly-Assisted 2019 175
HTS_SELF 15-19, Male, Unassisted 2019 175
HTS_SELF 20-24, Female, Directly-Assisted 2019 175
HTS_SELF 20-24, Female, Unassisted 2019 314
HTS_SELF 20-24, Male, Directly-Assisted 2019 35
HTS_SELF 20-24, Male, Unassisted 2019 175
HTS_SELF 25-29, Female, Directly-Assisted 2019 35
HTS_SELF 25-29, Female, Unassisted 2019 175
HTS_SELF 25-29, Male, Unassisted 2019 175
HTS_SELF 30-34, Female, Directly-Assisted 2019 35
HTS_SELF 30-34, Female, Unassisted 2019 175
HTS_SELF 30-34, Male, Directly-Assisted 2019 35
HTS_SELF 30-34, Male, Unassisted 2019 175
HTS_SELF 35-39, Female, Directly-Assisted 2019 35
HTS_SELF 35-39, Female, Unassisted 2019 175
HTS_SELF 35-39, Male, Directly-Assisted 2019 35
HTS_SELF 35-39, Male, Unassisted 2019 175
HTS_SELF 40-49, Female, Directly-Assisted 2019 175
HTS_SELF 40-49, Female, Unassisted 2019 175
HTS_SELF 40-49, Male, Directly-Assisted 2019 175
HTS_SELF 40-49, Male, Unassisted 2019 175
HTS_SELF 50+, Female, Unassisted 2019 175
HTS_SELF Directly-Assisted 2019 1,083
HTS_SELF FSW, Unassisted 2019 698
HTS_SELF Unassisted 2019 2,409
HTS_TST 25-29, Female, Negative 2019 1,440
HTS_TST 25-29, Female, Negative 2019 57
HTS_TST 25-29, Male, Negative 2019 1,440
HTS_TST 25-29, Male, Negative 2019 57
HTS_TST 30-34, Female, Negative 2019 1,440
HTS_TST 30-34, Female, Negative 2019 57
HTS_TST 30-34, Male, Negative 2019 720
HTS_TST 30-34, Male, Negative 2019 57
HTS_TST 35-39, Female, Negative 2019 720
HTS_TST 35-39, Female, Negative 2019 57
HTS_TST 35-39, Male, Negative 2019 720
HTS_TST 35-39, Male, Negative 2019 51
HTS_TST 40-49, Female, Negative 2019 1,440
HTS_TST 40-49, Female, Negative 2019 51
HTS_TST 40-49, Male, Negative 2019 1,440
HTS_TST 40-49, Male, Negative 2019 51
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 19,003
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 84
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 9
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 37
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 17
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 56
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 112
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 6
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 6
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 1,676
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 1,006
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 393
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 658
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 862
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 2,160
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 435
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 461
HTS_TST_POS 25-29, Female, Positive 2019 105
HTS_TST_POS 25-29, Female, Positive 2019 3
HTS_TST_POS 25-29, Male, Positive 2019 105
HTS_TST_POS 25-29, Male, Positive 2019 3
HTS_TST_POS 30-34, Female, Positive 2019 63
HTS_TST_POS 30-34, Female, Positive 2019 3
HTS_TST_POS 30-34, Male, Positive 2019 105
HTS_TST_POS 30-34, Male, Positive 2019 3
HTS_TST_POS 35-39, Female, Positive 2019 105
HTS_TST_POS 35-39, Female, Positive 2019 3
HTS_TST_POS 35-39, Male, Positive 2019 84
HTS_TST_POS 35-39, Male, Positive 2019 3
HTS_TST_POS 40-49, Female, Positive 2019 73
HTS_TST_POS 40-49, Female, Positive 2019 3
HTS_TST_POS 40-49, Male, Positive 2019 52
HTS_TST_POS 40-49, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 33
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2019 44
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 42
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 105
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 94
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 92
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 17
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 600
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 600
PP_PREV 25-29, Female 2019 501
PP_PREV 25-29, Male 2019 939
PP_PREV 30-34, Female 2019 438
PP_PREV 30-34, Male 2019 438
PP_PREV 35-39, Female 2019 313
PP_PREV 35-39, Male 2019 313
PP_PREV 40-49, Female 2019 125
PP_PREV 40-49, Male 2019 188
PP_PREV Age/sex: 10-14 Female 2019 63
PP_PREV Age/sex: 15-19 Female 2019 313
PP_PREV Age/sex: 15-19 Male 2019 188
PP_PREV Age/sex: 20-24 Female 2019 689
PP_PREV Age/sex: 20-24 Male 2019 1,691
PP_PREV Age/sex: 50+ Female 2019 25
PP_PREV Age/sex: 50+ Male 2019 64
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 6,288
PP_PREV Sum of Age/Sex disaggregates 2019 3,033
PrEP_NEW 25-29, Female 2019 15
PrEP_NEW 30-34, Female 2019 12
PrEP_NEW 35-39, Female 2019 12
PrEP_NEW 40-49, Female 2019 3
PrEP_NEW Female 15-19 2019 3
PrEP_NEW Female 20-24 2019 15
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 60
TX_NEW 25-29, Female, Positive 2019 24
TX_NEW 25-29, Male, Positive 2019 68
TX_NEW 30-34, Female, Positive 2019 25
TX_NEW 30-34, Male, Positive 2019 67
TX_NEW 35-39, Female, Positive 2019 24
TX_NEW 35-39, Male, Positive 2019 67
TX_NEW 40-49, Female, Positive 2019 24
TX_NEW 40-49, Male, Positive 2019 67
TX_NEW By Age/Sex: 10-14 Female 2019 3
TX_NEW By Age/Sex: 10-14 Male 2019 28
TX_NEW By Age/Sex: 15-19 Female 2019 2
TX_NEW By Age/Sex: 15-19 Male 2019 28
TX_NEW By Age/Sex: 20-24 Female 2019 12
TX_NEW By Age/Sex: 20-24 Male 2019 48
TX_NEW By Age/Sex: 50+ Female 2019 43
TX_NEW By Age/Sex: 50+ Male 2019 20
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 550
TX_NEW Sum of Age/Sex disaggregates 2019 184
Cross Cutting Budget Categories and Known Amounts Total: $101,375
Gender: Gender Based Violence (GBV) $101,375
GBV Prevention
Collection and Use of Gender-related Strategic Information
Capacity building
Implementation